1 / 12

Losartan Market Size, Share and Forcast

The Losartan market is steadily expanding, driven by the global prevalence of hypertension and the availability of affordable generics, with the market's value expected to reach over $2.6 billion by 2033.

Geeta34
Download Presentation

Losartan Market Size, Share and Forcast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Losartan Market Report Market Size, Share & Forecast (2021–2033) Welcome to the Global Losartan Market presentation. According to Cognitive Market Research, the Losartan market is witnessing steady expansion due to rising cases of hypertension and cardiovascular diseases worldwide. This presentation provides an in-depth view of market performance, forecasts, drivers, leading countries, and future opportunities through 2033.

  2. Global Market Size & Growth Forecast (2021–2033) $1,567.02M $1,873M $2,675.85M 4.56% 2021 Revenue 2025 Forecast 2033 Forecast CAGR Global Losartan market revenue Expected market value Projected market value Growth rate from 2025 to 2033 This growth is driven by the increasing need for affordable antihypertensive therapies and the expansion of healthcare access across developing nations.

  3. Key Market Drivers & Restraints Key Drivers: Key Restraints: Global Hypertension Prevalence Drug Substitutes and Combinations An aging global population and lifestyle-related disorders continue to drive Losartan prescriptions. Preference for combination therapies or newer ARBs could limit standalone Losartan growth. Affordability and Generic Penetration Patent Expiry and Pricing Pressures Availability of cost-effective generics makes Losartan a widely used first-line antihypertensive agent. Price erosion in key markets due to intense generic competition poses challenges. Favorable Treatment Guidelines Supply Chain Disruptions Many national and global treatment protocols include Losartan for patients with comorbidities like diabetes or kidney disease. Manufacturing and raw material dependencies can lead to periodic shortages, especially in emerging economies.

  4. Emerging Market Trends Increased Use in Combination Therapies Losartan is being increasingly paired with diuretics and calcium channel blockers, boosting demand for fixed-dose combinations. Telehealth Expansion Driving Prescriptions With the rise of digital consultations, prescription volume is growing for chronic disease drugs like Losartan. Regional Formulation Innovations Local manufacturers in Asia and Latin America are focusing on fast-release and patient-friendly formulations for better adherence.

  5. Top Companies in the Market Major pharmaceutical companies driving the global Losartan market include: Merck & Co., Inc. Teva Pharmaceutical Industries Ltd. Cipla Ltd. Torrent Pharmaceuticals Ltd. Zydus Lifesciences Ltd. Mylan N.V. (Viatris) These players focus on high-volume generics production, global export, and strengthening distribution partnerships across continents. Sun Pharmaceutical Industries Ltd. is also a major player in this market.

  6. Top Countries Forecast – All Years Revenue & CAGR This slide presents the top-performing countries based on market revenue in 2021, 2025, and 2033, along with their projected CAGR (2025–2033). On the left, a bar graph highlights revenue growth trends, while on the right, a detailed data table outlines the precise figures. Revenue Growth by Country Detailed Country Data Country 2021 2025 2033 CAGR (2025–2033) United States $444.83M $509.92M $668.05M 3.434% China $129.78M $166.59M $267.04M 6.076% India $39.19M $53.90M $100.55M 8.106% Germany $90.29M $109.94M $161.77M 4.947% 2021 2025 2033 Brazil $40.98M $50.74M $77.26M 5.396%

  7. Regional Insights & Highlights North America Remains the dominant region due to high diagnosis rates and prescription volumes. The U.S. leads with strong generics consumption. Europe Is showing moderate growth led by Germany, the UK, and France, with stable demand in chronic care segments. Asia Pacific Is the fastest-growing region, especially India and China, driven by population size, hypertension burden, and improving access to care. South America & Africa Offer emerging opportunities due to expanding public health initiatives and increasing cardiovascular disease incidence.

  8. Future Opportunities in the Market Government Initiatives Public screening and treatment programs in Asia and Africa will boost long-term demand. 1 Development of Dual-Action Pills 2 Innovation in multi-drug fixed-dose therapies incorporating Losartan can improve patient adherence. Contract Manufacturing & Export Growth Global pharma firms are increasingly outsourcing Losartan manufacturing to cost-efficient regions, enhancing market efficiency. 3

  9. Conclusion According to Cognitive Market Research, the global Losartan market is set to grow from $1,567.02 million in 2021 to $2,675.85 million by 2033, with a CAGR of 4.56% between 2025 and 2033. With increasing global focus on hypertension management and affordable generics, Losartan is expected to remain a key pharmaceutical ingredient in cardiovascular care. Strategic innovation, expanding access, and consistent demand across continents will shape its future outlook. For more information visit our report: Click here

  10. COGNITIVE MARKET RESEARCH TRUSTED BY GLOBAL INDUSTRY LEADERS Cognitive Market Research is a global market intelligence and consulting firm trusted by decision-makers in over 100 countries. Headquartered in the U.S., with offices in the U.K., India, and other strategic regions, we offer 24/7 support and seamless global coordination. Our expertise spans across 15+ industries, including healthcare, chemicals, energy, technology, consumer goods, manufacturing, automotive, and BFSI. We deliver scalable, client-centric solutions with quick turnaround times and a strong focus on quality. Supported by a skilled team of researchers, analysts, and data scientists, we use advanced analytics, proprietary tools, and deep domain knowledge to provide accurate, actionable insights. With a client-first approach, we’ve completed over 15,000 projects and 100,000+ interviews for startups, SMEs, Fortune 500s, and government agencies. Our tech-enabled, expert-driven methodologies make us a trusted partner for strategic decisions, innovation, and sustainable growth. WWW.COGNITIVEMARKETRESEARCH.COM

  11. RESEARCH METHODOLOGY CERTIFICATIONS & GLOBAL TRUST • 1. PRIMARY RESEARCH • Methods: Surveys, interviews, focus groups, consumer observation • Expert inputs: KOLs, C-level leaders, customers • 2. SECONDARY RESEARCH • Sources: Industry reports, databases (Statista, Factiva), • corporate filings • 3. DATA VALIDATION • Bottom-Up + Top-Down analysis • Triangulation with internal and external sources • 4. DELIVERABLES • REPorts in PPT, PDF, Word • SaaS platform and dashboard-based formats WWW.COGNITIVEMARKETRESEARCH.COM

  12. SPEAK TO ANALYST sales@cognitivemarketresearch.com USA: (+1) 312-376-8303 Europe and UK: (+44) 20-8144-9523 Asia Pacific: (+852) 81930785 India: (+91) 983-496-8611 WWW.COGNITIVEMARKETRESEARCH.COM

More Related